BIRDX
Price
$7.99
Change
-$0.01 (-0.12%)
Updated
Apr 25 closing price
Net Assets
217.29M
MGLAX
Price
$15.72
Change
-$0.01 (-0.06%)
Updated
Apr 25 closing price
Net Assets
2.21B
Ad is loading...

BIRDX vs MGLAX

Header iconBIRDX vs MGLAX Comparison
Open Charts BIRDX vs MGLAXBanner chart's image
iShares Developed Real Estate Idx Instl
Price$7.99
Change-$0.01 (-0.12%)
VolumeN/A
Net Assets217.29M
MFS Global Real Estate A
Price$15.72
Change-$0.01 (-0.06%)
VolumeN/A
Net Assets2.21B
BIRDX vs MGLAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
BIRDX vs. MGLAX commentary
Apr 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BIRDX is a Buy and MGLAX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
MGLAX has more cash in the bank: 2.21B vs. BIRDX (217M). BIRDX pays higher dividends than MGLAX: BIRDX (3.07) vs MGLAX (2.33). BIRDX was incepted earlier than MGLAX: BIRDX (10 years) vs MGLAX (16 years). MGLAX (1.20) is less costly to investors than BIRDX (0.20). MGLAX is a more actively managed with annual turnover of: 48.00 vs. BIRDX (3.00). MGLAX has a lower initial minimum investment than BIRDX: MGLAX (1000) vs BIRDX (2000000). MGLAX annual gain was more profitable for investors over the last year : 3.60 vs. BIRDX (-6.09). MGLAX return over 5 years is better than : 20.74 vs. BIRDX (15.39).
BIRDXMGLAXBIRDX / MGLAX
Total Expense Ratio0.201.1917%
Annual Report Gross Expense Ratio0.201.2017%
Fund Existence10 years16 years-
Gain YTD1.807-1.688-107%
Front LoadN/A6%-
Min. Initial Investment20000001000200,000%
Min. Initial Investment IRAN/AN/A-
Net Assets217M2.21B10%
Annual Yield % from dividends3.072.33132%
Returns for 1 year-6.093.60-169%
Returns for 3 years-22.35-20.20111%
Returns for 5 years15.3920.7474%
Returns for 10 yearsN/A17.03-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
JNGLX66.670.11
+0.17%
Janus Henderson Global Life Sciences D
GTDDX33.38N/A
N/A
Invesco EQV Emerging Markets All Cap A
GSVPX14.92N/A
N/A
Goldman Sachs Small/Mid Cap Value P
WMIDX10.95N/A
N/A
WCM Mid Cap Quality Value Investor
VVIEX11.76N/A
N/A
VOYA VACS Index Series EM Portfolio